Multicenter study for anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with metabolic syndrome.
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2011
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hypercholesterolaemia; Metabolic syndrome
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2007 Status changed from initiated to recruiting.